In this work, we observed that higher expression of the signature genes CD4, KLRG-1, and B3GAT1 correlated with a higher survival rate when we analyzed the OS of patients from two invasive breast carcinoma cohorts from the TCGA consortium. This evidence concerns the gene CD4 and invasive breast carcinoma.